Neil Kumar
CEO and President at BridgeBio Pharma Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: BridgeBio Pharma Inc., 3 years.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 16, 2024 | BridgeBio Pharma Inc. | Option exercise | +60,667 | โ | โ |
| May 16, 2024 | BridgeBio Pharma Inc. | Shares withheld for tax | โ30,748 | $31.04 | $954,418 |
| Feb 16, 2024 | BridgeBio Pharma Inc. | Option exercise | +102,249 | โ | โ |
| Feb 16, 2024 | BridgeBio Pharma Inc. | Shares withheld for tax | โ47,922 | $37.21 | $1,783,178 |
| Nov 17, 2023 | BridgeBio Pharma Inc. | Open-market sale | โ51,352 | $29.10 | $1,494,343 |
| Nov 17, 2023 | BridgeBio Pharma Inc. | Open-market sale | โ200 | $29.55 | $5,910 |
| Nov 16, 2023 | BridgeBio Pharma Inc. | Option exercise | +102,249 | โ | โ |
| Nov 16, 2023 | BridgeBio Pharma Inc. | Shares withheld for tax | โ50,697 | $28.86 | $1,463,115 |
| Aug 17, 2023 | BridgeBio Pharma Inc. | Open-market sale | โ51,552 | $28.59 | $1,473,872 |
| Aug 16, 2023 | BridgeBio Pharma Inc. | Option exercise | +102,250 | โ | โ |
| Aug 16, 2023 | BridgeBio Pharma Inc. | Shares withheld for tax | โ50,698 | $29.80 | $1,510,800 |
| May 17, 2023 | BridgeBio Pharma Inc. | Open-market sale | โ51,552 | $14.01 | $722,244 |
| May 16, 2023 | BridgeBio Pharma Inc. | Option exercise | +102,249 | โ | โ |
| May 16, 2023 | BridgeBio Pharma Inc. | Shares withheld for tax | โ50,697 | $14.09 | $714,321 |
| May 3, 2023 | BridgeBio Pharma Inc. | Open-market sale | โ120,000 | $14.18 | $1,701,600 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.